Skip to content
Open access

Temporal lymphatic tissue destruction and impairment of de novo T cell responses after an acute virus infection

Sep 2026 · Cell Death & Disease · 0 citations

TL;DR

The results highlight the complex interplay between virus infections, immune responses, and tissue integrity, challenging the common assumption that hosts fully recover their pre-infection homeostatic health state directly after an acute virus infection is controlled.

Abstract

Post-acute infection sequelae (PAIS), which include diverse immunological alterations and clinical syndromes, represent a significant yet poorly understood phenomenon following acute viral infections. While the host typically resolves acute infections within weeks and develops virus-specific immunity, emerging evidence suggests that long-term symptoms can persist or arise after primary infection recovery. Using the acute lymphocytic choriomeningitis virus (LCMV) infection mouse model, we investigated potential mechanisms underlying immune-related PAIS. By combining mouse infections, different vaccine regimens, and immune monitoring with fluorescence microscopy and 3D image reconstruction of lymphatic tissues, we demonstrated that LCMV-recovered animals exhibit a prolonged immunocompromised state affecting dominantly de novo T cell responses. This is linked to the massive destruction of splenic lymphatic tissue, affecting the compartmentalization of the organ as well as crucial cell–cell contacts necessary for efficient T cell priming. Importantly, LCMV vaccination prevented LCMV-mediated lymphatic tissue destruction and the compromised immunological state. These findings underscore the importance of vaccination in preventing both acute virus infection-mediated pathology and potential PAIS. Our results highlight the complex interplay between virus infections, immune responses, and tissue integrity, challenging the common assumption that hosts fully recover their pre-infection homeostatic health state directly after an acute virus infection is controlled.

Read PDF

Similar papers

Review Sep 2026

T-cell immunity in human herpesvirus vaccine development: research advances and translational challenges.

Human herpesviruses are widespread, establish lifelong latency, undergo intermittent or context-dependent reactivation, and cause diverse clinical manifestations. These features distinguish herpesvirus vaccine development from that for most acute infections. For indications involving latency, reactivation, or virus-ass...

Yu-Xin Shao, Zheng-De Xie, Ran Wang · 0 citations
Open access Sep 2026

Type 2 immune history trains lung macrophages for viral disease tolerance.

Severe respiratory viral disease varies widely among individuals and often reflects immunopathology rather than inadequate pathogen control, suggesting that previous immune history can prime the lungs towards disease tolerance. Here we show that nerve- and airway-associated macrophages (NAMs), a subset of interstitial...

P. Damani-Yokota, Y. Yordanov, Eduardo D. Bernier et al. · 0 citations
Open access Aug 2026

Pre-existing Th1 immunity is abrogated by ongoing recruitment of monocytic host cells that are refractory to activation

Protective immunity against many infectious diseases develops following primary infection, called infection induced immunity (III), and provides a blueprint for vaccination. However, many vaccination strategies have failed. In the parasitic Leishmania major model of self-healing cutaneous disease, control of secondary...

M. Carneiro, S. A. E. Soares, Chris Tiessen et al. · 0 citations
Open access Sep 2026

Distinct phases of immune system programming during ART-suppressed immunodeficiency virus infection.

People living with HIV (PLWH) on suppressive antiretroviral therapy (ART) can face non-AIDS complications, partially driven by chronic immune activation. To define immune perturbations during ART-suppressed viral infection, we performed longitudinal single-cell transcriptomic and plasma proteomic analyses of rhesus mac...

Maanasa Kaza, B. Varco-Merth, G. McElfresh et al. · 0 citations
Open access Sep 2026

HIGH DOSE GAMMAHERPESVIRUS INFECTION IN MACROPHAGES RESULTS IN INFLAMMATORY MULTIMODAL CELL DEATH

It is found that the amount of virus macrophages are exposed to determines the likelihood of survival versus an inflammatory death mediated by integrated programmed cell death mechanisms, which can be inhibited by Necrostatin-1, a promising treatment for multiple inflammatory diseases.

Gabrielle Vragel, Gracyn Nelson-Reid, Rachael E. Kostelecky et al. · 0 citations
Review Open access Aug 2026

Innate immunity-mediated inflammation and immunopathogenesis in HSV-1-infected encephalitis.

HSV-1 encephalitis (HSE) remains a devastating viral infection of the central nervous system despite effective antiviral therapy. Increasing evidence indicates that disease outcome is not determined by viral replication alone but by how innate immunity is calibrated within the brain. Studies of host susceptibility in c...

Sheng Yang, Yang-Kun Shen, Chunfu Zheng · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.